Masaru Koido
Polygenic architecture informs potential vulnerability to drug-induced liver injury
Koido, Masaru; Kawakami, Eri; Fukumura, Junko; Noguchi, Yui; Ohori, Momoko; Nio, Yasunori; Nicoletti, Paola; Aithal, Guruprasad P.; Daly, Ann K.; Watkins, Paul B.; Anayama, Hisashi; Dragan, Yvonne; Shinozawa, Tadahiro; Takebe, Takanori
Authors
Eri Kawakami
Junko Fukumura
Yui Noguchi
Momoko Ohori
Yasunori Nio
Paola Nicoletti
Professor GURUPRASAD AITHAL Guru.Aithal@nottingham.ac.uk
PROFESSOR OF HEPATOLOGY
Ann K. Daly
Paul B. Watkins
Hisashi Anayama
Yvonne Dragan
Tadahiro Shinozawa
Takanori Takebe
Abstract
Drug-Induced-Liver-Injury (DILI) is a leading cause of termination in drug development programs and removal of drugs from the market, and this is partially due to the inability to identify patients who are at risk1. Here, we developed a polygenic risk score (PRS) for DILI by aggregating effects of numerous genome-wide loci identified from previous large-scale genome-wide association studies (GWAS)2. The PRS predicted the susceptibility to DILI in patients treated with fasiglifam, amoxicillin-clavulanate or flucloxacillin, and in primary hepatocytes and stem cell-derived organoids from multiple donors treated with over 10 different drugs. Pathway analysis highlighted processes previously implicated in DILI, including unfolded protein responses and oxidative stress. In silico screening identified compounds that elicit transcriptomic signatures present in hepatocytes from individuals with elevated PRS, supporting mechanistic links and suggesting a novel screen for safety of new drug candidates. This genetic-, cellular-, organoid- and human-scale evidence underscored the polygenic architecture underlying DILI vulnerability at the level of hepatocytes, thus facilitating future mechanistic studies. Moreover, the proposed “polygenicity-in-a-dish” strategy might potentially inform designs of safer, more efficient, and robust clinical trials.
Citation
Koido, M., Kawakami, E., Fukumura, J., Noguchi, Y., Ohori, M., Nio, Y., Nicoletti, P., Aithal, G. P., Daly, A. K., Watkins, P. B., Anayama, H., Dragan, Y., Shinozawa, T., & Takebe, T. (2020). Polygenic architecture informs potential vulnerability to drug-induced liver injury. Nature Medicine, 26, 1541–1548. https://doi.org/10.1038/s41591-020-1023-0
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 20, 2020 |
Online Publication Date | Sep 7, 2020 |
Publication Date | Sep 7, 2020 |
Deposit Date | Jul 21, 2020 |
Publicly Available Date | Mar 8, 2021 |
Journal | Nature Medicine |
Print ISSN | 1078-8956 |
Electronic ISSN | 1546-170X |
Publisher | Nature Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 26 |
Pages | 1541–1548 |
DOI | https://doi.org/10.1038/s41591-020-1023-0 |
Public URL | https://nottingham-repository.worktribe.com/output/4780325 |
Publisher URL | https://www.nature.com/articles/s41591-020-1023-0 |
Files
Polygeneicity In Dish Nature Medicine Accepted
(6.8 Mb)
PDF
You might also like
Structuring white rice with gellan gum reduces the glycemic response in healthy humans
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search